We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
801
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $570K | ﹤0.01% |
846,533
| – | – |
|
802
Solid Power
SLDP
$475M
| $557K | ﹤0.01% |
160,526
-171,449
| -52% | -$646K |
|
803
Customers Bancorp
CUBI
$2.69B
| $554K | ﹤0.01% |
8,475
-370
| -4% | -$24.3K |
|
804
Radiant Logistics
RLGT
$411M
| $554K | ﹤0.01% |
93,868
-6,320
| -6% | -$38.9K |
|
805
Vir Biotechnology
VIR
$1.49B
| $552K | ﹤0.01% |
96,717
-48,581
| -33% | -$248K |
|
806
Brady Corp
BRC
$4.6B
| $551K | ﹤0.01% |
7,060
-5,846
| -45% | -$432K |
|
807
Ardmore Shipping
ASC
$669M
| $551K | ﹤0.01% |
+46,394
| New | +$520K |
|
808
Pliant Therapeutics
PLRX
$66.3M
| $543K | ﹤0.01% |
+367,113
| New | +$560K |
|
809
Vanda Pharmaceuticals
VNDA
$310M
| $542K | ﹤0.01% |
108,610
-57,383
| -35% | -$266K |
|
810
Playtika
PLTK
$1.51B
| $542K | ﹤0.01% |
139,292
-194,502
| -58% | -$794K |
|
811
First Commonwealth Financial
FCF
$2.17B
| $530K | ﹤0.01% |
31,076
-6,586
| -17% | -$112K |
|
812
Civista Bancshares
CIVB
$609M
| $528K | ﹤0.01% |
25,978
-4,258
| -14% | -$89.5K |
|
813
Oil States International
OIS
$483M
| $525K | ﹤0.01% |
86,684
-52,170
| -38% | -$286K |
|
814
Synopsys
SNPS
$73.5B
| $523K | ﹤0.01% |
+1,061
| New | +$600K |
|
815
State Street SPDR S&P 500 ETF Trust
SPY
$783B
| $520K | ﹤0.01% |
780
+180
| +30% | +$115K |
|
816
Steel Dynamics
STLD
$37.5B
| $518K | ﹤0.01% |
3,713
-85,700
| -96% | -$11.2M |
|
817
Sierra Bancorp
BSRR
$536M
| $517K | ﹤0.01% |
17,871
+480
| +3% | +$14.5K |
|
818
Phillips Edison & Co
PECO
$5.37B
| $514K | ﹤0.01% |
14,962
-55,352
| -79% | -$1.92M |
|
|
PSIX
819
Power Solutions International
PSIX
$643M
| $499K | ﹤0.01% |
+5,077
| New | +$450K |
|
820
Hormel Foods
HRL
$14.1B
| $495K | ﹤0.01% |
20,009
-949
| -5% | -$26.3K |
|
821
Leslie's
LESL
$9.83M
| $490K | ﹤0.01% |
89,064
-20,181
| -18% | -$149K |
|
822
Paychex
PAYX
$42.3B
| $489K | ﹤0.01% |
3,860
-288,785
| -99% | -$40.1M |
|
823
BCB Bancorp
BCBP
$186M
| $488K | ﹤0.01% |
56,170
+978
| +2% | +$8.54K |
|
824
Home Bancorp
HBCP
$563M
| $485K | ﹤0.01% |
8,936
+841
| +10% | +$46.1K |
|
|
MITT
825
TPG Mortgage Investment Trust
MITT
$230M
| $482K | ﹤0.01% |
66,607
+37,328
| +127% | +$283K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.